The latest news, announcements and press releases from Peptinovo Biopharma.
ANN ARBOR, Mich., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Peptinovo Biopharma, an Ann Arbor–based biotechnology company pioneering targeted cancer therapies through its proprietary PALM™ nanotechnology, today announced a major manufacturing and intellectual property milestone achieved in collaboration with Chemelectiva S.r.l., an Italian specialty pharmaceutical chemistry company. The breakthrough significantly advances Peptinovo’s proprietary prodrug platform for targeted chemotherapy delivery.
This is the News section of the company profile page for Peptinovo Biopharma on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
